SSA
INSM icon

Schonfeld Strategic Advisors’s Insmed INSM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,100
Closed -$1.32M – 2195
2024
Q3 		$1.32M Buy
+18,100
New +$1.34M 0.01% 1060

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Schonfeld Strategic Advisors's INSM Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Insmed (INSM) stake by 86% in Q2 2026, buying an estimated $5.85M and bringing the position to 104,378 shares worth $11.1M. The position accounts for 0.04% of the portfolio, ranked #390.

Schonfeld Strategic Advisors first reported a position in INSM in Q2 2017 and has held it in 21 quarters since. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Schonfeld Strategic Advisors held 104,378 shares of Insmed worth $11.1M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 48,322 Insmed shares in Q2 2026, an estimated $5.85M.
  • Insmed made up 0.04% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #390 holding.
  • Schonfeld Strategic Advisors first reported a position in Insmed in Q2 2017 and has held it in 21 quarters since.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.